Authors:
Bellosillo, B
Villamor, N
Lopez-Guillermo, A
Marce, S
Esteve, J
Campo, E
Colomer, D
Montserrat, E
Citation: B. Bellosillo et al., Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species, BLOOD, 98(9), 2001, pp. 2771-2777
Authors:
Hernandez, S
Hernandez, L
Bea, S
Pinyol, M
Nayach, I
Bellosillo, B
Nadal, A
Ferrer, A
Fernandez, PL
Montserrat, E
Cardesa, A
Campo, E
Citation: S. Hernandez et al., cdc25A and the splicing variant cdc25B2, but not cdc25B1, -B3 or -C, are over-expressed in aggressive human non-Hodgkin's lymphomas, INT J CANC, 89(2), 2000, pp. 148-152
Authors:
Bellosillo, B
Villamor, N
Colomer, D
Pons, G
Montserrat, E
Gil, J
Citation: B. Bellosillo et al., In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia, BLOOD, 94(8), 1999, pp. 2836-2843
Citation: B. Bellosillo et J. Gil, Induction of apoptosis by salicylates in B-cell chronic lymphocytic leukemia - Response, BLOOD, 93(3), 1999, pp. 1124-1124